Literature DB >> 10505081

NIH-FDA Conference: Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications. Abstracts.

.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 10505081      PMCID： PMC3850843          DOI： 10.1155/1998/698239

Source DB:  PubMed          Journal:  Dis Markers        ISSN： 0278-0240            Impact factor:   3.434


× No keyword cloud information.
  4 in total

Review 1.  A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials.

Authors:  David J Hunter; Elena Losina; Ali Guermazi; Deb Burstein; Marissa N Lassere; Virginia Kraus
Journal:  Curr Drug Targets       Date:  2010-05       Impact factor: 3.465

Review 2.  Systematic review of the concurrent and predictive validity of MRI biomarkers in OA.

Authors:  D J Hunter; W Zhang; Philip G Conaghan; K Hirko; L Menashe; L Li; W M Reichmann; E Losina
Journal:  Osteoarthritis Cartilage       Date:  2011-03-23       Impact factor: 6.576

3.  Molecular functional imaging in personalized clinical oncology: The road less traveled.

Authors:  Abhishek Mahajan; Subhash Desai; Ameya Shirish Kawthalkar; Meenakshi Haresh Thakur
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Jan-Mar

Review 4.  Significant function and research progress of biomarkers in gastric cancer.

Authors:  Dong Mei Ye; Gaosheng Xu; Wei Ma; Yuxuan Li; Weiru Luo; Yiyang Xiao; Yong Liu; Zhiwei Zhang
Journal:  Oncol Lett       Date:  2019-11-11       Impact factor: 2.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.